Announced Wed, 13 May · 18:27 IST

Please Find the Attached Monitoring Agency Report for the Quarter ended on March 31, 2026

KINGFA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹5170.00
prior close
₹5146.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.0+2.3+2.6+2.6+0.3+3.0+1.8+1.2-0.5+1.0+2.9-2.5-3.0
Up moveDown movePending
AI summary

CARE Ratings Limited, as the Monitoring Agency, submitted its quarterly report on the Rs.500 crore preferential issue proceeds utilization for Kingfa Science & Technology India Limited. As of March 31, 2026, the company has utilized Rs.155.78 crore (31.2% of total proceeds), with Rs.344.22 crore remaining unutilized. During Q4FY26, Rs.40.63 crore was deployed towards General Corporate Purpose (vendor payments and bank charges), and Rs.60.29 crore was deployed towards Plant and Machinery (out of Rs.102 crore allocated). The unutilized funds are parked in Fixed Deposits with ICBC Bank (Rs.285 crore across different maturities) and savings accounts (Rs.62.12 crore), earning approximately Rs.8.55 crore in accrued interest. No deviations from the objects of the issue were observed. All projects have a target completion date of June 2027.

Likely market impact

For shareholders, this filing confirms that the company is utilizing preferential issue proceeds as disclosed, with no material deviations. The significant unutilized balance (68.8%) parked in FDs suggests a phased capital deployment approach, which is typical for infrastructure and expansion projects. The GCP utilization indicates normal business operations continue.